Search

Erasca Inc

Cerrado

17.88 -3.61

Resumen

Variación precio

24h

Actual

Mínimo

17.62

Máximo

18.34

Métricas clave

By Trading Economics

Ingresos

-154M

-183M

BPA

-0.6

Empleados

103

EBITDA

-151M

-183M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+21.05% upside

Dividendos

By Acuity

Próximas Ganancias

10 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

2.4B

5.7B

Apertura anterior

21.49

Cierre anterior

17.88

Erasca Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

12 jul 2026, 23:51 UTC

Cryptocurrency market mixed as Bitcoin dips and Ethereum rises ahead of key U.S. inflation data releases impacting Federal Reserve policy.

12 jul 2026, 23:51 UTC

Markets brace for key U.S. inflation and retail sales data releases, with potential implications for Federal Reserve policy amid ongoing economic pressures.

12 jul 2026, 23:51 UTC

Cryptocurrency market shows mixed performance ahead of key U.S. inflation data, as Federal Reserve signals focus on AI in monetary policy.

12 jul 2026, 23:51 UTC

Cryptocurrency market shows mixed performance ahead of critical U.S. economic data releases that may impact Federal Reserve monetary policy.

12 jul 2026, 23:51 UTC

Bank of Korea Expected to Maintain Interest Rate at 2.5% Amid Rising Inflation and Economic Uncertainty

12 jul 2026, 23:51 UTC

China's House Price Index YoY Release on July 15 Expected to Show Continued Decline Amidst Ongoing Property Sector Challenges and Global Economic Uncertainty.

12 jul 2026, 23:41 UTC

US Import Prices Expected to Decrease by 0.4% Amid Cautious Market Sentiment and Geopolitical Tensions Ahead of Key Economic Data Releases

12 jul 2026, 23:41 UTC

Housing Starts Data Release on July 17, 2026: Analysts Brace for Weakness Amid High Mortgage Rates and Economic Pressures.

12 jul 2026, 23:41 UTC

US Export Prices Expected to Rise Amid Inflation Concerns and Geopolitical Tensions Ahead of Key Economic Data Releases

12 jul 2026, 23:41 UTC

U.S. Building Permits MoM Prel for June 2026 Set to Release Amid Heightened Focus on Housing Trends and Legislative Changes

12 jul 2026, 23:41 UTC

Upcoming U.S. Housing Starts Data Release on July 17 Expected to Influence Economic Outlook Amid Legislative Changes and Key Macroeconomic Indicators.

12 jul 2026, 23:41 UTC

U.S. Building Permits Data Release on July 17 Expected to Show Annualized Rate of 1.42 Million Amid Cautious Market Sentiment and Key Macroeconomic Indicators Ahead.

12 jul 2026, 23:41 UTC

Macro News
Correlated Moves

The US 30Y Treasury Bond Index is lower as capital shifts to technology sectors, with rising oil prices amid U.S.-Iran tensions impacting safe-haven demand.

12 jul 2026, 23:31 UTC

Australia's NAB Business Confidence Index set for release amid cautious sentiment and global economic uncertainties.

12 jul 2026, 23:21 UTC

Philadelphia Fed Manufacturing Index Release on July 16 Expected to Show Moderate Optimism Amidst Cautious Market Sentiment and Geopolitical Tensions.

12 jul 2026, 23:21 UTC

U.S. Retail Sales Expected to Rise 0.3% in June Amid Cautious Optimism and Key Economic Indicators Ahead of Fed Policy Insights

12 jul 2026, 23:21 UTC

U.S. Retail Sales Ex Autos Expected to Decline 0.1% in June Amid Economic Caution and Geopolitical Tensions

12 jul 2026, 23:11 UTC

Canada's housing starts data set for July 16, 2026, expected to show resilience with a forecast of 260K units amid positive government initiatives.

12 jul 2026, 23:01 UTC

NZD/CHF has moved higher in after-market trading, currently 1.22% above its 20-day moving average. No specific news was identified for the price move.

12 jul 2026, 23:01 UTC

Macro News
Correlated Moves

The U.S. dollar strengthens against major currencies, contributing to a modest after-hours gain in USD/CHF amid rising geopolitical tensions and a higher Dollar Index.

12 jul 2026, 23:01 UTC

Macro News
Correlated Moves

GBP/USD is trading lower after the U.S. dollar strengthened against major currencies amid geopolitical tensions and anticipation of key macroeconomic data releases.

12 jul 2026, 23:01 UTC

Macro News

The U.S. dollar rose today, reaching a two-day high against the euro amid geopolitical tensions with Iran affecting shipping route stability.

12 jul 2026, 23:01 UTC

Market anticipates NY Empire State Manufacturing Index reading of 8.7 amid cautious sentiment ahead of key macroeconomic data releases.

12 jul 2026, 23:01 UTC

Core PPI for June 2026 set to rise by 0.4% MoM, signaling cautious market sentiment ahead of key economic indicators and Federal Reserve insights.

12 jul 2026, 23:01 UTC

Market Braces for July 15 PPI Release Amid Anticipated 0.2% Increase and Heightened Volatility from Geopolitical Tensions.

12 jul 2026, 23:01 UTC

The EUR/HUF is trading higher after-market, reaching a session high earlier. Market focus remains on upcoming U.S. inflation data that may impact Fed policy.

12 jul 2026, 23:01 UTC

Palladium is trading lower today, continuing a decline since Friday's close. Market focus remains on upcoming U.S. economic data releases.

12 jul 2026, 23:01 UTC

Macro News
Correlated Moves

Gold prices are lower amid a stronger U.S. dollar and renewed U.S.-Iran military tensions, impacting market sentiment toward safe-haven assets.

12 jul 2026, 23:01 UTC

EUR/NOK is trading lower in after-market hours, reflecting a decline since Friday's close. The price remains near the midpoint of its one-month range.

12 jul 2026, 23:01 UTC

Macro News

Copper prices are lower as geopolitical tensions rise amid U.S.-Iran confrontations. Reports of Iraq's oil agreements may further impact market dynamics.

Comparación entre iguales

Cambio de precio

Erasca Inc previsión

Precio Objetivo

By TipRanks

21.05% repunte

Estimación a 12 Meses

Media 22.43 USD  21.05%

Máximo 30 USD

Mínimo 16 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Erasca Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

7 ratings

6

Comprar

1

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
help-icon Live chat